Immune to Cancer: The CRI Blog
-
CRI Funded Scientist
Jun Hu, PhD
-
CRI Funded Scientist
Jonggul John Kim, PhD
-
CRI Funded Scientist
Philip Kranzusch, PhD
Human cells use signals called “nucleotide second messengers” to stimulate the immune response and prevent disease. These… -
CRI Funded Scientist
Matteo Bellone, MD
-
CRI Funded Scientist
Ping-Chih Ho, PhD
Checkpoint immunotherapies harnessing cancer-killing T cells represent a major breakthrough in cancer treatment. However, solid tumors often have… -
CRI Funded Scientist
Gavin Peter Dunn, MD, PhD
Dr. Dunn focuses on understanding the immune response to malignant brain cancers and how to use this knowledge to… -
CRI Funded Scientist
Amanda Lund, PhD
As an inaugural CRI Lloyd J. Old STAR, Dr. Amanda Lund aims to develop a better understanding… -
CRI Funded Scientist
Maria Kathleen Traver, PhD
-
CRI Funded Scientist
Joshua D. Brody, MD
As a CRI Lloyd J. Old STAR, Dr. Brody is investigating a therapeutic cancer vaccine approach—known as in situ…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.